U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. DDT COA #000113: Chronic Heart Failure- Impact Scale (CHF-IS)
  1. Drug Development Tool (DDT) Qualification Programs

DDT COA #000113: Chronic Heart Failure- Impact Scale (CHF-IS)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Drug Evaluation (ODE) I
Division of Cardiovascular and Renal Products (DCaRP)

DDT COA Number
DDT COA #000113

Instrument Name
Chronic Heart Failure- Impact Scale (CHF-IS)

Disease/Condition
Chronic Heart Failure

Concept of Interest
CHF Symptom impacts

Context of Use
Patients with CHF

COA Type
PRO

Qualification Stage
Letter of Intent- Accepted 

Requestor(s)
Critical Path Institute: Patient- Reported Outcome (PRO) Consortium, Chronic Heart Failure Working Group

Contact(s)
Stephen Coons

Date Accepted into CDER’s COA Qualification Program
April 30, 2019

Submission and Regulatory Correspondence History

Qualification Submission

Date

FDA Submission Decision & Recommendations

Date

Letter of Intent

1/14/19

FDA Response (Accepted)

4/30/19

Back to Clinical Outcome Assessments (COA) Qualification Submission